ASHP: Key Role for Pharmacists in Natural, Man-Made Disasters

This article originally appeared here.
Share this content:
ASHP: Key Role for Pharmacists in Natural, Man-Made Disasters
ASHP: Key Role for Pharmacists in Natural, Man-Made Disasters

TUESDAY, Dec. 5, 2017 (HealthDay News) -- Pharmacy specialists play a critical role in preparing for and responding to disastrous events, according to an educational session held at the mid-year clinical meeting and exhibition of the American Society of Health-System Pharmacists, held from Dec. 3 to 7 in Orlando, Fla.

The session presenters provided insight into the role pharmacy specialists and pharmacy departments play during natural and man-made disasters. They also discussed the principles of mass casualty incident triage and provided an overview of the issues that commonly arise during mass casualty incidents.

By using real world examples, the lecturers outlined lessons learned and highlighted the injury patterns and pharmacy needs of those impacted by disastrous events. They also discussed implementation of disaster management plans based on this information. According to one of the presenters, keeping it simple and sticking to being prepared, responding appropriately, and evaluating lessons learned are all key elements in providing effective responses to disastrous events.

"Given their drug expertise, pharmacists should play an active role in disaster preparedness planning locally and at large," according to the presenters. "Pharmacy leaders should create a robust pharmacy emergency operations plan for pharmacy staff to utilize during planned and unplanned disasters. Pharmacy staff should undergo both written and active routine training for disasters using the facility and pharmacy emergency operations plan to best prepare for disasters."

Abstract
Presentation Slides
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Lab  Companion Tests Perform Similarly for Oncology Analytes

Lab + Companion Tests Perform Similarly for Oncology ...

Findings based on comparison of tests to diagnose oncology-related genetic variants

Ulixertinib Is Active in Patients With Advanced Solid Tumors

Ulixertinib Is Active in Patients With Advanced Solid ...

Responses occurred in patients with NRAS-, BRAF V600-, non-V600 BRAF-mutant solid tumors

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

Doctors Must Report on at Least 1 Patient, ...

To avoid Medicare payment penalty in 2019, clinicians must report by Dec. 31, submit by Feb. 28

is free, fast, and customized just for you!

Already a member?

Sign In Now »